(Q38426164)

3 September 2017

title

Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: has WHO offered a milestone for HIV prevention? (English)

1 reference

World Health Organization

3 September 2017

main subject

0 references

anti-retroviral agent

0 references

Sub-Saharan Africa

0 references

prevention of HIV/AIDS

0 references

author name string

Sonia Menon

series ordinal

1

1 reference

3 September 2017

language of work or name

1 reference

1 December 2010

1 reference

Journal of Public Health Policy

3 September 2017

published in

1 reference

3 September 2017

volume

31

1 reference

3 September 2017

issue

4

1 reference

3 September 2017

page(s)

385-400

1 reference

https://scigraph.springernature.com/pub.10.1057/jphp.2010.29

3 September 2017

exact match

0 references

cites work

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

The host immune response to tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

Effect of treating co-infections on HIV-1 viral load: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

The prevalence of antiretroviral drug resistance in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

When to start antiretroviral therapy--ready when you are?

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

When to start antiretroviral therapy in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

Immune reconstitution inflammatory syndrome: more answers, more questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

Scaling up HIV prevention: why routine or mandatory testing is not feasible for sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

Scaling up stigma? The effects of antiretroviral roll-out on stigma and HIV testing. Early evidence from rural Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

Immune control of HIV-1 after early treatment of acute infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1057%2FJPHP.2010.29

21 January 2018

Identifiers

DOI

10.1057/JPHP.2010.29

1 reference

Dimensions Publication ID

3 September 2017

1020028920

0 references

1 reference